Skip to content
2000
Volume 9, Issue 1
  • ISSN: 1389-5575
  • E-ISSN: 1875-5607

Abstract

In this review article we have reported a series of hybrid compounds characterized by the presence of a α- halogenocryloyl alkylating moiety of low chemical reactivity, linked to known antitumor agents or their active moieties. Among them, brostallicin (PNU-166196), was selected for clinical development and is now undergoing Phase II studies in patients with advanced or metastatic soft tissue sarcoma.

Loading

Article metrics loading...

/content/journals/mrmc/10.2174/138955709787001640
2009-01-01
2025-11-01
Loading full text...

Full text loading...

/content/journals/mrmc/10.2174/138955709787001640
Loading

  • Article Type:
    Research Article
Keyword(s): Antitumor agents; apoptosis; Distamycin A; hybrid molecules; α-bromoacryloyl
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test